Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel
NASDAQ:GCTK

GlucoTrack Q1 2025 Earnings Report

GlucoTrack logo
$0.67 +0.00 (+0.67%)
Closing price 04:00 PM Eastern
Extended Trading
$0.67 +0.00 (+0.54%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

GlucoTrack EPS Results

Actual EPS
-$20.40
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GlucoTrack Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GlucoTrack Announcement Details

Quarter
Q1 2025
Date
5/14/2025
Time
After Market Closes
Conference Call Date
Wednesday, May 14, 2025
Conference Call Time
4:00PM ET

Conference Call Resources

Powered by Quartr

Earnings Documents

GlucoTrack's Q1 2025 Press ReleasePress Release
(8-K)
GlucoTrack's Q1 2025 Quarterly reportQuarterly report
(10-Q)

GlucoTrack Earnings Headlines

GlucoTrack (NASDAQ:GCTK) Upgraded to "Sell" at Wall Street Zen
May 30, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30808482
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions
May 26, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/glucotrack-to-highlight-implantable-continuous-blood-glucose-monitoring-technology-at-the-american-diabetes-association-s-2026-scientific-sessions-1036193706
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
June 3 at 1:00 AM  |  Profits Run (Ad)
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association's 2026 Scientific Sessions
May 26, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/26/3301032/0/en/glucotrack-to-highlight-implantable-continuous-blood-glucose-monitoring-technology-at-the-american-diabetes-association-s-2026-scientific-sessions.html
GlucoTrack, Inc.: Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 15, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-05/68505758-glucotrack-inc-glucotrack-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights-399.htm
Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/14/3295471/0/en/glucotrack-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights.html
See More GlucoTrack Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GlucoTrack? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GlucoTrack and other key companies, straight to your email.

About GlucoTrack

GlucoTrack (NASDAQ:GCTK), a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

View GlucoTrack Profile
Earnings Tools